Style | Citing Format |
---|---|
MLA | Esmaeili A, et al.. "A Pilot Randomized, Clinical Trial of the Anti-Pruritus Effect of Melatonin in Patients With Chronic Liver Disease." Iranian Journal of Pharmaceutical Research, vol. 20, no. 2, 2021, pp. 462-472. |
APA | Esmaeili A, Toosi MN, Taher M, Merat S, Bayani J, Karimian ZF, Esmaeili A, Moazzami B, Namazi S (2021). A Pilot Randomized, Clinical Trial of the Anti-Pruritus Effect of Melatonin in Patients With Chronic Liver Disease. Iranian Journal of Pharmaceutical Research, 20(2), 462-472. |
Chicago | Esmaeili A, Toosi MN, Taher M, Merat S, Bayani J, Karimian ZF, Esmaeili A, Moazzami B, Namazi S. "A Pilot Randomized, Clinical Trial of the Anti-Pruritus Effect of Melatonin in Patients With Chronic Liver Disease." Iranian Journal of Pharmaceutical Research 20, no. 2 (2021): 462-472. |
Harvard | Esmaeili A et al. (2021) 'A Pilot Randomized, Clinical Trial of the Anti-Pruritus Effect of Melatonin in Patients With Chronic Liver Disease', Iranian Journal of Pharmaceutical Research, 20(2), pp. 462-472. |
Vancouver | Esmaeili A, Toosi MN, Taher M, Merat S, Bayani J, Karimian ZF, et al.. A Pilot Randomized, Clinical Trial of the Anti-Pruritus Effect of Melatonin in Patients With Chronic Liver Disease. Iranian Journal of Pharmaceutical Research. 2021;20(2):462-472. |
BibTex | @article{ author = {Esmaeili A and Toosi MN and Taher M and Merat S and Bayani J and Karimian ZF and Esmaeili A and Moazzami B and Namazi S}, title = {A Pilot Randomized, Clinical Trial of the Anti-Pruritus Effect of Melatonin in Patients With Chronic Liver Disease}, journal = {Iranian Journal of Pharmaceutical Research}, volume = {20}, number = {2}, pages = {462-472}, year = {2021} } |
RIS | TY - JOUR AU - Esmaeili A AU - Toosi MN AU - Taher M AU - Merat S AU - Bayani J AU - Karimian ZF AU - Esmaeili A AU - Moazzami B AU - Namazi S TI - A Pilot Randomized, Clinical Trial of the Anti-Pruritus Effect of Melatonin in Patients With Chronic Liver Disease JO - Iranian Journal of Pharmaceutical Research VL - 20 IS - 2 SP - 462 EP - 472 PY - 2021 ER - |